Business News • MarketWire • Mercury Capital II Limited Enters Into Definitive Agreement and Files Filing Statement on Sedar in Connection with Proposed Qualifying Transaction with Revive Therapeutics Inc.

Mercury Capital II Limited Enters Into Definitive Agreement and Files Filing Statement on Sedar in Connection with Proposed Qualifying Transaction with Revive Therapeutics Inc.

Mercury Capital II Limited Enters Into Definitive Agreement and Files Filing Statement on Sedar in Connection with Proposed Qualifying Transaction with Revive Therapeutics Inc.

TORONTO, ONTARIO--(Marketwired - Nov. 27, 2013) - Mercury Capital II Limited. ("Mercury") (TSX VENTURE:MFF.P), a capital pool company as defined under Policy 2.4 of the TSX Venture Exchange (the "Exchange"), is pleased to provide this update on the proposed arm's length acquisition of 100% of the common shares of Revive Therapeutics Inc. ("Revive") by Mercury previously announced on July 18, 2013. Pursuant to the terms of an amalgamation agreement dated November 26, 2013 (the "Amalgamation Agreement") and subject to completion of certain conditions precedent, including, completion of a concurrent financing and receipt of all necessary regulatory and Exchange approvals, the proposed acquisition of Revive will qualify as Mercury 's "Qualifying Transaction" as defined by Exchange Policy 2.4.

View More : http://www.marketwired.com/mw/release.do?id=1857146&sourceType=3

Releted News by marketwire

LX Ventures Completes $3 Million Financing

Selon BMO, les aînés s'accordent une bonne note en matière de connaissances financières... mais la littératie financière constitue une démarche permanente